For: | Marques I, Araújo A, Mello RA. Anti-angiogenic therapies for metastatic colorectal cancer: Current and future perspectives. World J Gastroenterol 2013; 19(44): 7955-7971 [PMID: 24307789 DOI: 10.3748/wjg.v19.i44.7955] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v19/i44/7955.htm |
Number | Citing Articles |
1 |
Ramon Andrade De Mello, Luis Castelo-Branco, Pedro Castelo-Branco, Daniel Humberto Pozza, Louis Vermeulen, Sofia Palacio, Matthew Salzberg, A. Craig Lockhart. What Will We Expect From Novel Therapies to Esophageal and Gastric Malignancies?. American Society of Clinical Oncology Educational Book 2018; (38): 249 doi: 10.1200/EDBK_198805
|
2 |
Ralf S. Eschbach, Wolfgang P. Fendler, Philipp M. Kazmierczak, Marcus Hacker, Axel Rominger, Janette Carlsen, Heidrun Hirner-Eppeneder, Jessica Schuster, Matthias Moser, Lukas Havla, Moritz J. Schneider, Michael Ingrisch, Lukas Spaeth, Maximilian F. Reiser, Konstantin Nikolaou, Clemens C. Cyran, Roger Chammas. Correlation of Perfusion MRI and 18F-FDG PET Imaging Biomarkers for Monitoring Regorafenib Therapy in Experimental Colon Carcinomas with Immunohistochemical Validation. PLOS ONE 2015; 10(2): e0115543 doi: 10.1371/journal.pone.0115543
|
3 |
Dao-Hong Chen, Xiao-Shi Zhang. Targeted therapy: resistance and re-sensitization. Chinese Journal of Cancer 2015; 34(3) doi: 10.1186/s40880-015-0047-1
|
4 |
Juan Garona, Marina Pifano, Giselle Ripoll, Daniel F. Alonso. Vasopressin. Vitamins and Hormones 2020; 113: 259 doi: 10.1016/bs.vh.2019.08.010
|
5 |
Estíbaliz Echazarreta-Gallego, Manuela Elía-Guedea, Elena Córdoba-Díaz de Laspra. Devastadora complicación tras tratamiento con aflibercept. Cirugía y Cirujanos 2017; 85(3): 260 doi: 10.1016/j.circir.2016.03.011
|
6 |
Duarte Mendes Oliveira, Katia Grillone, Chiara Mignogna, Valentina De Falco, Carmelo Laudanna, Flavia Biamonte, Rosa Locane, Francesco Corcione, Massimiliano Fabozzi, Rosario Sacco, Giuseppe Viglietto, Donatella Malanga, Antonia Rizzuto. Next-generation sequencing analysis of receptor-type tyrosine kinase genes in surgically resected colon cancer: identification of gain-of-function mutations in the RET proto-oncogene. Journal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0746-y
|
7 |
Christine Wittig, Claudia Scheuer, Julia Parakenings, Michael D. Menger, Matthias W. Laschke, Christina Lynn Addison. Geraniol Suppresses Angiogenesis by Downregulating Vascular Endothelial Growth Factor (VEGF)/VEGFR-2 Signaling. PLOS ONE 2015; 10(7): e0131946 doi: 10.1371/journal.pone.0131946
|
8 |
Jianwei Wang, Jinhui Zhu, Mingjun Dong, Hua Yu, Xiaoyu Dai, Keqiang Li. RETRACTION: Inhibition of protein phosphatase 5 (PP5) suppresses survival and growth of colorectal cancer cells. Biotechnology and Applied Biochemistry 2015; 62(5): 621 doi: 10.1002/bab.1308
|
9 |
HYUNG-HOON OH, KANG-JIN PARK, NURI KIM, SUN-YOUNG PARK, YOUNG-LAN PARK, CHAN-YOUNG OAK, DAE-SEONG MYUNG, SUNG-BUM CHO, WAN-SIK LEE, KYUNG-KEUN KIM, YOUNG-EUN JOO. Impact of KITENIN on tumor angiogenesis and lymphangiogenesis in colorectal cancer. Oncology Reports 2016; 35(1): 253 doi: 10.3892/or.2015.4337
|
10 |
Yinshuang Chen, Man Yang, Fanyi Meng, Yawen Zhang, Mengmeng Wang, Xuqin Guo, Jie Yang, Hongjian Zhang, Haiyang Zhang, Jing Sun, Weipeng Wang. SRSF3 Promotes Angiogenesis in Colorectal Cancer by Splicing SRF. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.810610
|
11 |
Nahal Eshghifar, Elham Badrlou, Farkhondeh Pouresmaeili. The roles of miRNAs’ clinical efficiencies in the colorectal cancer pathobiology: A review article. Human Antibodies 2020; 28(4): 273 doi: 10.3233/HAB-200417
|
12 |
Włodzimierz Otto, Finlay Macrae, Janusz Sierdziński, Justyna Smaga, Maria Król, Ewa Wilińska, Krzysztof Zieniewicz. Microsatellite instability and manifestations of angiogenesis in stage IV of sporadic colorectal carcinoma. Medicine 2019; 98(1): e13956 doi: 10.1097/MD.0000000000013956
|
13 |
Jin‐Lian Ma, Ting Zhang, Feng‐Zhi Suo, Jiao Chang, Xiang‐Bin Wan, Xue‐Jian Feng, Yi‐Chao Zheng, Hong‐Min Liu. Lysine‐specific demethylase 1 activation by vitamin B2 attenuates efficacy of apatinib for proliferation and migration of gastric cancer cell MGC‐803. Journal of Cellular Biochemistry 2018; 119(6): 4957 doi: 10.1002/jcb.26741
|
14 |
Hans Raskov, Hans-Christian Pommergaard, Jakob Burcharth, Jacob Rosenberg. Colorectal carcinogenesis-update and perspectives. World Journal of Gastroenterology 2014; 20(48): 18151-18164 doi: 10.3748/wjg.v20.i48.18151
|
15 |
Araceli Valverde, Jon Peñarando, Amanda Cañas, Laura M. López-Sánchez, Francisco Conde, Vanessa Hernández, Esther Peralbo, Chary López-Pedrera, Juan de la Haba-Rodríguez, Enrique Aranda, Antonio Rodríguez-Ariza, Daotai Nie. Simultaneous Inhibition of EGFR/VEGFR and Cyclooxygenase-2 Targets Stemness-Related Pathways in Colorectal Cancer Cells. PLOS ONE 2015; 10(6): e0131363 doi: 10.1371/journal.pone.0131363
|
16 |
Estíbaliz Echazarreta-Gallego, Manuela Elía-Guedea, Elena Córdoba-Díaz de Laspra. Devastating surgical complications after aflibercept chemotherapy. Cirugía y Cirujanos (English Edition) 2017; 85(3): 260 doi: 10.1016/j.circen.2017.05.008
|
17 |
NURI KIM, SUNG-BUM CHO, YOUNG-LAN PARK, SUN-YOUNG PARK, EUN MYUNG, SEUNG-HUN KIM, HYUNG-MIN YU, YOUNG-AE SON, DAE-SEONG MYUNG, WAN-SIK LEE, YOUNG-EUN JOO. Effect of Recepteur d'Origine Nantais expression on chemosensitivity and tumor cell behavior in colorectal cancer. Oncology Reports 2016; 35(6): 3331 doi: 10.3892/or.2016.4721
|
18 |
Lu CHEN, Wen-Ling WANG, Teng-Fei SONG, Xin XIE, Xue-Wei YE, Ying LIANG, Hao-Cai HUANG, Shi-Lun YAN, Xiao-Yuan LIAN, Zhi-Zhen ZHANG. Anti-colorectal cancer effects of tripolinolate A from Tripolium vulgare. Chinese Journal of Natural Medicines 2017; 15(8): 576 doi: 10.1016/S1875-5364(17)30085-7
|
19 |
Liqun Yang, Zhigang Dong, Shuyu Li, Tieliang Chen. ESM1 promotes angiogenesis in colorectal cancer by activating PI3K/Akt/mTOR pathway, thus accelerating tumor progression. Aging 2023; doi: 10.18632/aging.204559
|
20 |
Nourhan Hossam, Marwa Matboli, Hanan H. Shehata, Marwa M. Aboelhussein, Mohamed Kamel Hassan, Sanaa Eissa. Toll-like receptor immune modulatory role in personalized management of colorectal cancer, review of literature. Expert Review of Precision Medicine and Drug Development 2020; 5(6): 455 doi: 10.1080/23808993.2020.1816136
|
21 |
Omar Abdel-Rahman, Mona Fouad. Correlation of cetuximab-induced skin rash and outcomes of solid tumor patients treated with cetuximab: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology 2015; 93(2): 127 doi: 10.1016/j.critrevonc.2014.07.005
|
22 |
Xiao Xiao, Zhiguo Liu, Rui Wang, Jiayin Wang, Song Zhang, Xiqiang Cai, Kaichun Wu, Raymond C. Bergan, Li Xu, Daiming Fan. Genistein suppresses FLT4 and inhibits human colorectal cancer metastasis. Oncotarget 2015; 6(5): 3225 doi: 10.18632/oncotarget.3064
|
23 |
Armin Wiegering, Doreen Korb, Andreas Thalheimer, Ulrike Kämmerer, Jan Allmanritter, Niels Matthes, Michael Linnebacher, Nicolas Schlegel, Ingo Klein, Süleyman Ergün, Christoph-Thomas Germer, Christoph Otto. E7080 (Lenvatinib), a Multi-Targeted Tyrosine Kinase Inhibitor, Demonstrates Antitumor Activities Against Colorectal Cancer Xenografts. Neoplasia 2014; 16(11): 972 doi: 10.1016/j.neo.2014.09.008
|
24 |
Yuji Takayama, Koichi Suzuki, Yuta Muto, Kosuke Ichida, Taro Fukui, Nao Kakizawa, Hideki Ishikawa, Fumiaki Watanabe, Fumi Hasegawa, Masaaki Saito, Shingo Tsujinaka, Kazushige Futsuhara, Yasuyuki Miyakura, Hiroshi Noda, Fumio Konishi, Toshiki Rikiyama. Monitoring circulating tumor DNA revealed dynamic changes inKRASstatus in patients with metastatic colorectal cancer. Oncotarget 2018; 9(36): 24398 doi: 10.18632/oncotarget.25309
|
25 |
Juan Garona, Natasha T. Sobol, Marina Pifano, Valeria I. Segatori, Daniel E. Gomez, Giselle V. Ripoll, Daniel F. Alonso. Preclinical Efficacy of [V4 Q5 ]dDAVP, a Second Generation Vasopressin Analog, on Metastatic Spread and Tumor-Associated Angiogenesis in Colorectal Cancer. Cancer Research and Treatment 2019; 51(2): 438 doi: 10.4143/crt.2018.040
|
26 |
Ramon Andrade de Mello, Jailson de Oliveira, Georgios Antoniou. Angiogenesis and apatinib: a new hope for patients with advanced gastric cancer?. Future Oncology 2017; 13(4): 295 doi: 10.2217/fon-2016-0318
|